Norway has participated in the work of the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) since 1.1.2001. The center is an EU institution and has the task of collecting and analyzing information and knowledge about drugs and drug policy issues. The Norwegian Institute of Public Health (FHI) is commissioned by the Ministry of Health and Care Services (HOD) to be the national focal point. This entails participation in the information network (REITOX) that links the national focal points in the Member States and enables electronic exchange of data across Europe. The task as a national focal point requires the collection, processing and reporting of a wide range of information about the drug situation in Norway. The Norwegian focal point for the EMCDDA is headed by Thomas Anton Sandøy and Ola Røed Bilgrei.
See the full project description at Cristin for more information about results, researchers, contact information etc.
Solveig Tobie Glestad Christiansen, Avdeling for rusmidler og tobakk, Norwegian Institute of Public Health
Thomas Clausen, Norwegian Centre for Addiction Research, University of Oslo
Rikard Rykkvin, Avdeling for tuberkulose, blod- og seksuell smitte, Norwegian Institute of Public Health
Ellen Johanna Amundsen, Avdeling for rusmidler og tobakk, Norwegian Institute of Public Health
Ola Røed Bilgrei, Avdeling for rusmidler og tobakk, Norwegian Institute of Public Health
Jasmina Burdzovic, Avdeling for rusmidler og tobakk, Norwegian Institute of Public Health
Kai Arild Holm, Kripos